Skip to main content

Table 3 LogMRA visual acuity at baseline and during each follow-up visit after UCP

From: Efficacy and safety of high-intensity focused ultrasound cyclo-plasty in glaucoma

 

Follow-up number (n)

Preoperative BCVA

Follow-up BCVA

Z

p

Vision unchanged(n,%)

Vison loss 1 line(n,%)

Vision loss ≥2 lines(n,%)

Day 1

20

0.40 (0.13, 0.98)

0.55 (0.30, 0.90)

-1.985

0.047

12(60)

1(5)

7(35)

Day 7

18

0.50 (0.18, 1.03)

0.60 (0.38, 1.00)

-0.912

0.362

9(50)

3(16.7)

6(33.3)

Month 1

15

0.40 (0.10, 1.00)

0.70 (0.50, 1.10)

-1.486

0.137

8(53.3)

2(13.3)

5(33.3)

Month 3

15

0.40 (0.10, 1.00)

0.70 (0.40, 1.00)

-1.261

0.207

5(33.3)

2(13.3)

8(53.3)

Month 6

17

0.40 (0.10, 0.95)

0.70 (0.20, 1.00)

-1.462

0.144

7(41.2)

2(11.8)

8(47.1)

Month 12

9

0.80 (0.35, 1.15)

1.00 (0.45, 2.30)

-1.352

0.176

5(55.6)

0

4(44.4)

Month 18

5

0.80 (0.30, 1.00)

1.30 (0.20, 3.00)

-1.461

0.144

2(40)

0

3(60)

  1. Bold values are statistically significant